NASDAQ · Biotechnology

SPRY (SPRY) Stock

$5.13 -8.88% NASDAQ: SPRY Healthcare

Valuation

MetricValue
Price$5.13
Market Cap$509.43M
P/E Ratio-10.25
P/B Ratio8.52
P/S Ratio9.84
EPS (TTM)$-1.74
52-Week High$18.90
52-Week Low$5.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-136.40%
ROA-41.15%
ROCE-155.65%
Gross Margin77.10%
Operating Margin-2.04%
Net Margin-2.00%
Debt/Equity1.58
Current Ratio7.31

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.0M$1.0M$0$89.0M$84.0M
Operating Profit$-19.0M$-36.0M$-68.0M$-3.0M$-179.0M
Net Profit$-20.0M$-35.0M$-54.0M$8.0M$-171.0M
EPS$-0.70$-0.87$-0.57$0.08$-1.74
Op Margin-353.3%-2698.8%-225066.7%-3.5%-212.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$61.0M$281.0M$233.0M$351.0M$328.0M
Total Liabilities$93.0M$9.0M$2.0M$94.0M$213.0M
Cash$60.0M$211.0M$71.0M$51.0M$41.0M
Borrowings$9.0M$0$0$0$96.0M

Latest News

ARS Pharmaceuticals (SPRY) Appoints Donn Casale As The New CEO Insider Monkey · Jul 15, 2026 Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength? Zacks · Jul 8, 2026 ARS Pharmaceuticals Names Donn Casale as CEO as Richard Lowenthal Departs MT Newswires · Jul 7, 2026 ARS Pharmaceuticals Announces CEO Succession GlobeNewswire · Jul 7, 2026 ARS Pharmaceuticals (SPRY) Is Down 11.5% After Losing Spots in Key Russell 2000 Defensive Indices Simply Wall St. · Jun 29, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-18.0M$-40.0M$-59.0M$14.0M$-171.0M
Investing Cash Flow$0$0$-87.0M$-107.0M$56.0M
Financing Cash Flow$0$199.0M$0$0$3.0M
Net Cash Flow$36.0M$150.0M$-140.0M$-20.0M$-9.0M
Free Cash Flow$-18.0M$-40.0M$-59.0M$13.0M$-171.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-4.67
FCF Yield-18.00%
Quick Ratio4.77
Interest Coverage-59.67
Return 1Y-66.67%
Return 3Y-18.48%
Return 5Y-74.64%

Ownership

Insiders Held16.21%
Institutions Held94.46%
Institutions Float Held112.74%
Institutional HolderSharesReport Date
RA Capital Management, L.P.10,860,9772026-03-31
Orbimed Advisors LLC.8,288,5102026-03-31
Rubric Capital Management LP8,000,0002026-03-31
Deerfield Management Company, L.P7,503,8122026-03-31
Millennium Management Llc5,982,9192026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABUS $4.41 +0.00% -25.41 $871.14M 0.00%
GHRS $29.10 -0.06% -10.34 $2.00B 0.00%
KURA $9.57 +3.13% -2.90 $849.57M 0.00%
LENZ $5.05 +1.10% -3.18 $158.34M 0.00%
NBTXNanobiotix S.A. $40.18 +1.21% -68.71 $2.03B 0.00%

About SPRY

SPRY is led by CEO Richard E. Lowenthal, employs 155 people, headquartered in US, publicly traded since 2020.

SPRY stock trades at $5.13 with a market capitalization of $509.43M. The stock is valued at a price-to-earnings (P/E) ratio of -10.25, price-to-book of 8.52, price-to-sales of 9.84. Over the past 52 weeks the stock has ranged between $5.13 and $18.90, and currently trades 72.9% below its 52-week high.

On profitability, SPRY generates a return on equity (ROE) of -136.40%, return on capital employed of -155.65%, an operating margin of -2.04%, a net profit margin of -2.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides